[6-K] Cre8 Enterprise Limited Current Report (Foreign Issuer)

Rhea-AI Filing Summary

Cre8 Enterprise Limited (NASDAQ: CRE) disclosed that American Trust Investment Services, acting as lead underwriter, fully exercised the IPO over-allotment option on 28 Jul 2025. The option covered 217,500 Class A ordinary shares at the original offering price of US$4.00 per share; closing occurred on 30 Jul 2025.

The exercise supplied an extra US$0.87 million in gross proceeds, bringing total IPO gross proceeds to US$6.67 million before underwriting discounts and related expenses. A press release detailing the transaction is included as Exhibit 99.1.

The full greenshoe take-up indicates healthy aftermarket demand and adds incremental liquidity for corporate uses, albeit with a slight increase in share count and dilution to existing holders.

Positive

• Full greenshoe exercise implies strong aftermarket demand for CRE shares
• US$0.87 million additional capital lifts total IPO proceeds to US$6.67 million
• Increased public float may improve liquidity and institutional interest

Negative

• Slight shareholder dilution from issuing 217,500 additional shares
• Proceeds remain modest relative to typical growth-capital needs

Insights

IPO Analyst

TL;DR: Full greenshoe exercise signals strong demand, adds liquidity, limited but positive impact.

The complete take-up of the 15% over-allotment validates underwriter pricing and market appetite post-listing. Although the additional capital is modest, it enhances near-term cash while expanding the public float—improving trading liquidity and index eligibility prospects. With proceeds now at US$6.67 million, management gains incremental runway without further marketing costs. Dilution is minimal, as investors expected this possibility at IPO pricing.

Portfolio Manager

TL;DR: Small cash boost; positive sentiment outweighs minor dilution.

From a portfolio standpoint, the event is marginally accretive. The 217,500-share issue raises cash equal to roughly 13% of initial proceeds, supporting working capital while adding just ~3% to the outstanding share base. Such participation by underwriters often stabilizes post-IPO price action, suggesting reduced near-term volatility. However, given the company’s micro-cap size, the financial impact remains limited in absolute terms.

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Form 6-K

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934

For the month of July 2025

Commission File Number: 001-42759

Cre8 Enterprise Limited

(Translation of registrant’s name into English)

1/F, China Building
29 Queen’s Road Central, Hong Kong

(Address of principal executive office)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

Form 20-F ☒        Form 40-F ☐

On July 28, 2025, American Trust Investment Services, Inc., as the representative  (the “Representative”) of the underwriters in the initial public offering of Cre8 Enterprise Limited (the “Company”), exercised its over-allotment option (the “Over-allotment Option”) in full to purchase an additional 217,500 Class A Ordinary Shares of the Company (the “Additional Shares”) at the public offering price of US$4.00 per share. The closing for the sale of the Additional Shares took place on July 30, 2025.

The Company received US$870,000 in gross proceeds from the full exercise of the Over-allotment Option, before deducting underwriting discounts and other related expenses. As a result, the gross proceeds of the Company’s initial public offering totaled US$6.67 million, before deducting underwriting discounts and other related expenses.

A copy of the press release announcing the full exercise of the Over-allotment Option is attached as Exhibit 99.1 and incorporated herein by reference. This report does not constitute an offer to sell, or the solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation, or sale would be unlawful prior to the registration or qualification under the securities laws of any such state or jurisdiction. 

EXHIBITS INDEX

Exhibit No.		Description
99.1		Press Release dated July 30, 2025, announcing the full exercise of the over-allotment option

1

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

Date: July 30, 2025	Cre8 Enterprise Limited
	By:	/s/ Sze Ting CHO
	Name:	Sze Ting CHO
	Title:	Chief Executive Officer and Chairman of the Board

2

FAQ

How many additional Cre8 Enterprise (CRE) shares were sold under the over-allotment option?

Underwriters purchased 217,500 Class A ordinary shares.

What price was paid for the additional CRE shares?

The shares were sold at the original IPO price of US$4.00 each.

How much extra capital did Cre8 Enterprise raise from the greenshoe exercise?

Gross proceeds totaled US$870,000 before fees.

What are the total gross proceeds from Cre8 Enterprise’s IPO after the exercise?

Aggregate gross proceeds now stand at US$6.67 million.

When did the over-allotment purchase close?

The closing occurred on 30 July 2025.